Defining "True and Non-Misleading" for Pharmaceutical Promotion

J Law Med Ethics. 2018 Jun;46(2):552-554. doi: 10.1177/1073110518782970.

¹ Spencer Phillips Hey, Ph.D., is a Research Scientist in the Program on Regulation, Therapeutics, and Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women's Hospital and a faculty member at the Harvard Center for Bioethics in Boston. Aaron S. Kesselheim, M.D., J.D., M.P.H., is an Associate Professor of Medicine at Harvard Medical School and Director of the Program on Regulation, Therapeutics, and Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women's Hospital and a faculty member at the Harvard Center for Bioethics in Boston. He is also a faculty member at the Harvard Center for Bioethics.

No abstract available

Publication types